Physician profile
Lauren A Hansen
NPI 1285049767
$1,574.98
in general payments reported to CMS, 2019-2025
15 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $87.45 · 2021: $166 · 2022: $203 · 2023: $168 · 2024: $322 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $586.40 | 2019-2025 | Clareon, Rocklatan, Tryptyr |
| Sun Pharmaceutical Industries INC. | $184.94 | 2022-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $154.25 | 2022-2023 | Acthar |
| Oyster Point Pharma, INC. | $149.69 | 2022-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $122.37 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $98.35 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $95.46 | 2024-2025 | Xiidra, Scoutpro Osmolarity System, Infuse |
| Tarsus Pharmaceuticals, INC. | $47.19 | 2025 | Xdemvy |
| Coopervision INC. | $29.62 | 2022-2025 | Clariti Contact Lens |
| Abbvie INC. | $24.91 | 2025 | |
| Harrow Eye, LLC | $20.40 | 2024 | Flarex |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.88 | 2023 | Flarex |
| Leadiant Biosciences, INC. | $17.58 | 2022 | |
| Abb Con-Cise Optical Group LLC | $5.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.